Classification of deprescribing and its use in an elderly patient with cognitive impairment
- Authors: Krasnov G.S1, Bulgakova S.V1, Treneva E.V1, Zakharova N.O1, Nikolaeva A.V1, Rozhdestvenskaya O.A2
-
Affiliations:
- Samara State Medical University, Ministry of Health of Russia
- Academy of Postgraduate Education, Federal Research and Clinical Center, Federal Biomedical Agency of Russia
- Issue: Vol 32, No 6 (2021)
- Pages: 82-85
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114448
- DOI: https://doi.org/10.29296/25877305-2021-06-16
- ID: 114448
Cite item
Open Access
Access granted
Abstract
Deprescribing antihypertensive agents is a planned or situational process of discontinuation, replacement, and dose reduction, which is adequately controlled by a physician. The paper considers a case of deprescribing using the STOPP/ START criteria and expert evaluation in the hospital, and also provides a comparative assessment of the patients data at the hospital admission and before his discharge.
Keywords
Full Text
About the authors
G. S Krasnov
Samara State Medical University, Ministry of Health of Russia
S. V Bulgakova
Samara State Medical University, Ministry of Health of Russia
E. V Treneva
Samara State Medical University, Ministry of Health of Russia
N. O Zakharova
Samara State Medical University, Ministry of Health of Russia
A. V Nikolaeva
Samara State Medical University, Ministry of Health of Russia
O. A Rozhdestvenskaya
Academy of Postgraduate Education, Federal Research and Clinical Center, Federal Biomedical Agency of Russia
References
- Сычев Д.А. Полипрагмазия в клинической практике: проблема и способы решения. Учебное пособие, 2-е изд., испр. и доп. СПб: ЦОП «Профессия», 2018; 272 с
- Martin-Perez M., Lopez de Andres A., Hernandez-Barrera V. et al. Prevalence of polypharmacy among the population older than 65 years in Spain: Analysis of the 2006 and 2011/12 National Health Surveys. [Article in Spanish]. Rev Esp Geriatr Gerontol. 2017; 52 (1): 2-8. doi: 10.1016/j.regg.2016.07.006
- Депрескрайбинг ингибиторов протонной помпы у пациентов пожилого и старческого возраста. Проект протокола [Depreskraibing ingibitorov protonnoi pompy u patsientov pozhilogo i starcheskogo vozrasta. Proekt protokola (in Russ.)]. URL: https://rgnkc.ru/images/pdf_documets/Depreskraibing/Depreskraibing_2_0_1.pdf
- Fick D.M., Semla T.P., Steinman M. et al. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J. Am Geriatr Soc. 2019; 67 (4): 674-94. doi: 10.1111/jgs.15767
- O’Mahony D., O’Sullivan D., Byrne S. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014; 44 (2): 213-8. doi: 10.1093/ageing/afu145
- Pazan F., Weiss C., Wehling M. FORTA. The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People. Drugs Aging. 2018; 35 (1): 61-71. DOI: 10.1007/ s40266-017-0514-2
- Warle-van Herwaarden M.F., Kramers C., Sturkenboom M.C. et al. Dutch HARM-Wrestling Task Force. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf. 2012; 35 (3): 245-59. doi: 10.2165/11596000-000000000-00000
- Koponen M., Taipale H., Lavikainen P. et al. Risk of mortality associated with antipsychotic monotherapy and polypharmacy among community-dwelling persons with Alzheimer’s disease. J. Alzheimers Dis. 2017; 56: 107-18. doi: 10.3233/JAD-160671
- Koponen M., Taipale H., Tanskanen A. et al. Long-term use of antipsychotics among community-dwelling persons with Alzheimers disease: A nationwide register-based study. Eur Neuropsychopharmacol. 2015; 25: 1706-13. doi: 10.1016/j.euroneuro.2015.07.008
- Liperoti R., Sganga F., Landi F. et al. Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment. J. Clin Psychiatry. 2017; 78: e76-e82. doi: 10.4088/JCP.15m10303
- Pariente A., Fourrier-Reglat A., Ducruet T. et al. Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med. 2012; 172 (8): 648-53. doi: 10.1001/archinternmed.2012.28
- Proton Pump Inhibitors - How much for how long? URL: https://www.veteransmates.net.au/topic-32
- Garfinkel D., Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010; 170: 1648-54. doi: 10.1001/archinternmed.2010.355
- Garfinkel D. Poly-de-prescribing to treat polypharmacy: efficacy and safety. Ther Adv Drug Saf. 2017; 9 (1): 25-43. doi: 10.1177/2042098617736192
Supplementary files
